All News

The manufacturer of one of the cancer treatments announced that it is also participating in clinical trials assessing the safety and efficacy of their product in colorectal and endometrial cancer.

When a friend with metastatic breast cancer said that her cancer responded to treatment and she was excited to stop taking daily pills, I thought that something must have been miscommunicated to her.

The use of a chemotherapy-free, combination regimen as a maintenance treatment option was associated with an improvement in survival in a group of patients with advanced pancreatic cancer.

Watch Dr. Sherrif Ibrahim, Dr. Erica B. Friedman and Dr. Nicholas Sanfilippo answer questions about the multidisciplinary approach to care during the CURE Educated Patient Skin Cancer Summit.

The manufacturer of the novel CAR-T cell therapy announced it terminated an early-phase trial investigating the treatment’s efficacy after there was a lack of benefit in patients with relapsed or refractory T-cell lymphoma, a type of blood cancer.

A clinical trial reviewing the safety and efficacy of a treatment regimen of enoblituzumab in combination with either retifanlimab or tebotelimab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck has been stopped by the manufacturer of the cancer drugs.

After cancer, my “normal” life is long forgotten, but how can I get back to life as a person who is well?

Heartbreak and loss trail behind us every day in the cancer world. But so does understanding, friendship and love.

Watch Dr. Nicholas Sanfilippo, from Weill Cornell Medicine, discuss radiation therapy options during the CURE Educated Patient Skin Cancer Summit.

The FDA granted abelacimab a fast track designation for the treatment of thrombosis, a common and sometimes deadly type of blood clot associated with cancer.

The first patient was dosed in a phase 2 trial studying the efficacy of sapanisertib in patients with NRF2-mutant relapsed/refractory lung cancer.

After being diagnosed with cancer, I took a hard look at what I was eating and made some positive changes.

Thanks to the FDA approval of immunotherapy agents, the average survival for patients for stage 4 melanoma has drastically increased over the past 20 years, an expert explained.

Watch Dr. Erica B. Friedman, from NYU Grossman School of Medicine, discuss surgery, during the CURE Educated Patient Skin Cancer Summit.

Watch Dr. Sherrif Ibrahim, from the University of Rochester Medical Center, discuss topical treatments during the CURE Educated Patient Skin Cancer Summit.

Watch Dr. Barbara Ma, Dr. Evan Lipson, Dr. Sunandana Chandra and Samantha Guild answer questions on the basics of skin cancer and melanoma during the CURE Educated Patient Skin Cancer Summit.

Kerry Fraser, a survivor of a myeloproliferative neoplasm and retired NHL referee, explained how he came to be diagnosed, and his hopes for the future of the group of rare blood cancers.

The FDA approval of Breyanzi, a novel CAR-T cell therapy, provides many patients with lymphoma a new treatment option that can be used earlier in the course of their disease, according to an expert.

I typically don’t use cancer labels, such as “survivor” or “thriver,” but when I heard about COVID-19 “long-haulers,” the term resonated with me.

Treatment with praluzatamab ravtansine improved outcomes in some patients with breast cancer, though one expert noted further study of the drug is needed.

Watch Dr. Sunandan Chandra, from Northwestern University Feinberg School of Medicine, discuss the basics of melanoma, during the CURE Educated Patient Skin Cancer Summit.

I prefer when people respond with empathy when they hear about my wife’s death from cancer, though I’m often met with sympathy first.

According to the manufacturer, this is the first-in-human clinical trial of Allocetra combined with chemotherapy in patients with peritoneal metastases arising from solid cancers.

I did not wear my prosthetic breast for my son’s wedding, but I did pack some lymphedema essentials for my trip.

The priority review comes following positive clinical trial results, which may lead to a shift in the treatment paradigm for follicular lymphoma, according to an expert.

Watch Dr. Evan J. Lipson, from Johns Hopkins Medicine, discuss Merkel cell carcinoma, during the CURE Educated Patient Skin Cancer Summit.

In a clinical trial, the use of Tukysa plus Herceptin demonstrated promising results in treating patients with HER2-positive metastatic colorectal cancer.

After decades of dealing with type 1 diabetes, I was taking care of my ailing parents when I received a breast cancer diagnosis.

At a neighbor’s funeral, I realized that people have their own hardships, too, and there is a time and a place to discuss my cancer diagnosis.

The myeloma treatment group of the COVALENT-101 clinical trial recently started, analyzing the new drug BMF-219 in patients with relapsed or refractory disease.